Pages that link to "Q39414183"
Jump to navigation
Jump to search
The following pages link to The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. (Q39414183):
Displaying 50 items.
- PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs (Q43042008) (← links)
- Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection (Q45326057) (← links)
- Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver. (Q45531739) (← links)
- Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation (Q46431649) (← links)
- PARP1 protects from benzo[a]pyrene diol epoxide-induced replication stress and mutagenicity. (Q47339833) (← links)
- A transcriptomics approach uncovers novel roles for poly(ADP-ribosyl)ation in the basal defense response in Arabidopsis thaliana. (Q48336374) (← links)
- Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF. (Q49341124) (← links)
- Caught with One's Zinc Fingers in the Genome Integrity Cookie Jar. (Q49685857) (← links)
- Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks (Q49833942) (← links)
- Super-resolution imaging identifies PARP1 and the Ku complex acting as DNA double-strand break sensors (Q49977725) (← links)
- PARP1 depletion induces RIG-I-dependent signaling in human cancer cells. (Q51758824) (← links)
- Targeting NAD+/PARP DNA repair pathway as a novel therapeutic approach to SDHB-mutated cluster I pheochromocytoma and paraganglioma. (Q52325957) (← links)
- Update on PARP Inhibitors in Breast Cancer. (Q52592609) (← links)
- Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets. (Q55301235) (← links)
- Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor. (Q55312290) (← links)
- Destabilization of linker histone H1.2 is essential for ATM activation and DNA damage repair. (Q55406533) (← links)
- Parp3 promotes long-range end joining in murine cells (Q57050164) (← links)
- Profiles of Radioresistance Mechanisms in Prostate Cancer (Q57115094) (← links)
- Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options (Q57153919) (← links)
- Single-Strand Break End Resection in Genome Integrity: Mechanism and Regulation by APE2 (Q57169467) (← links)
- NRDE-2, the human homolog of fission yeast Nrl1, prevents DNA damage accumulation in human cells (Q57754053) (← links)
- PARP-1 (Poly[ADP-Ribose] Polymerase-1) (Q57787176) (← links)
- Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer (Q57810288) (← links)
- PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin (Q58747369) (← links)
- PARP2 mediates branched poly ADP-ribosylation in response to DNA damage (Q58786750) (← links)
- From “Cellular” RNA to “Smart” RNA: Multiple Roles of RNA in Genome Stability and Beyond (Q58862336) (← links)
- Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway (Q59137668) (← links)
- Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling (Q59140610) (← links)
- A sustained antiviral host response in respiratory syncytial virus infected human nasal epithelium does not prevent progeny virus production (Q59359689) (← links)
- Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors (Q60918179) (← links)
- Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance (Q61136915) (← links)
- EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation (Q61450799) (← links)
- Diastereomeric Recognition of 5',8-cyclo-2'-Deoxyadenosine Lesions by Human Poly(ADP-ribose) Polymerase 1 in a Biomimetic Model (Q62606194) (← links)
- Age-related gene and miRNA expression changes in airways of healthy individuals (Q63432940) (← links)
- Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase (Q64052640) (← links)
- Signal-induced PARP1-Erk synergism mediates IEG expression (Q64052985) (← links)
- Structural analyses of NudT16-ADP-ribose complexes direct rational design of mutants with improved processing of poly(ADP-ribosyl)ated proteins (Q64057286) (← links)
- Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies (Q64061652) (← links)
- Interactions of p53 with poly(ADP-ribose) and DNA induce distinct changes in protein structure as revealed by ATR-FTIR spectroscopy (Q64072077) (← links)
- DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors (Q64078978) (← links)
- Dose-dependent spatiotemporal responses of mammalian cells to an alkylating agent (Q64104986) (← links)
- Genetic Polymorphisms of DNA Repair Pathways in Sporadic Colorectal Carcinogenesis (Q64108459) (← links)
- Computational analysis of data from a genome-wide screening identifies new functional interactors as potential therapeutic targets (Q64120426) (← links)
- The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response (Q64236096) (← links)
- WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks (Q64387083) (← links)
- MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells (Q64387686) (← links)
- Phosphatase 1 Nuclear Targeting Subunit Mediates Recruitment and Function of Poly (ADP-Ribose) Polymerase 1 in DNA Repair (Q64387935) (← links)
- PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness (Q64388718) (← links)
- Integrating the DNA damage and protein stress responses during cancer development and treatment. (Q64883630) (← links)
- MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. (Q64921859) (← links)